Sign In
Buy VIVO
$3.90
+0.170 (+4.56%)
At Close: Aug 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
03:00am, Wednesday, 03'rd Mar 2021
NEW YORK, March 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advis
Here is Why Growth Investors Should Buy Meridian Bioscience (VIVO) Now
01:39pm, Monday, 01'st Mar 2021
Meridian Bioscience (VIVO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
5 Stocks With High Net Income Ratio to Scoop Up
09:08am, Thursday, 25'th Feb 2021
Profitability analysis is considered one of the best possible ways to assess the prospects of a company.
Is Meridian Bioscience (VIVO) Outperforming Other Medical Stocks This Year?
12:09pm, Wednesday, 24'th Feb 2021
Is (VIVO) Outperforming Other Medical Stocks This Year?
Meridian Bioscience issues correction: It can't ship its Revogene SARS-CoV-2 test until EUA is granted
01:47pm, Tuesday, 23'rd Feb 2021
Meridian Bioscience Inc. issued a statement Tuesday afternoon, to correct a statement made earlier regarding its SARS-CoV-2 molecular diagnostic test on its Revogene platform. The stock dropped 8.7%,
Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal
01:16pm, Tuesday, 23'rd Feb 2021
CINCINNATI, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, updated its communication regarding t
Meridian Bioscience Pulls Out Revogene COVID-19 Test EUA Application
09:33am, Tuesday, 23'rd Feb 2021
After submitting a written response to the FDA's request for additional information on Meridian Bioscience Inc's (NASDAQ: VIVO) Revogene SARS-CoV-2 test on February 16 and further discussions with
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission
08:00am, Tuesday, 23'rd Feb 2021
CINCINNATI, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided a further update on its appl
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
01:06pm, Monday, 22'nd Feb 2021
New York, New York--(Newsfile Corp. - February 22, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
09:47pm, Thursday, 18'th Feb 2021
NEW YORK, Feb. 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ: VIVO). Such investors are advis
Forget Profit, Bet on These 5 Stocks With Increasing Cash Flows
09:51am, Thursday, 18'th Feb 2021
Cash indicates a company's true financial health. It offers the flexibility to make decisions, the means to make potential investments and the fuel to run its growth engine.
Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission
08:00am, Tuesday, 16'th Feb 2021
CINCINNATI, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided an update on its application
6 Top-Ranked Stocks With Solid Net Profit Margins
07:35am, Tuesday, 16'th Feb 2021
Let's take a look at these six top-ranked stocks with impressive net profit margins for a winning portfolio.
Looking for a Growth Stock? 3 Reasons Why Meridian Bioscience (VIVO) is a Solid Choice
01:38pm, Friday, 12'th Feb 2021
Meridian Bioscience (VIVO) could produce exceptional returns because of its solid growth attributes.
Top Ranked Momentum Stocks to Buy for February 12th
12:07pm, Friday, 12'th Feb 2021
Top Ranked Momentum Stocks to Buy for February 12th
